Vigil Neuroscience (VIGL US)

Analysis

Health Care • United States

Vigil Neuroscience, Inc. operates as a biotechnology company. The Company focuses on discovering and developing novel therapeutics in basic science and human genetics of microglia. Vigil Neuroscience serves customers in the United States.

Refresh

Company Presentation • 10 Jan 2023 00:15

41st Annual J.P. Morgan Healthcare Conference

Company Presentation • 11 Jan 2024 23:30

J.P. Morgan 42nd Annual Healthcare Conference 2024

Company Presentation • 13 Sep 2023 19:30

Investor Update

Company Presentation • 17 Nov 2023 05:30

Investor Update

No more presentations

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00